{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:44:49Z","timestamp":1786463089678,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13760-026-03038-4","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:31:46Z","timestamp":1774247506000},"page":"1191-1199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comorbid autoimmune diseases do not influence long-term disability progression in multiple sclerosis"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5673-3014","authenticated-orcid":false,"given":"Ahmed Serkan","family":"Emekli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-0908","authenticated-orcid":false,"given":"Tuncay","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3286-2652","authenticated-orcid":false,"given":"Murat","family":"K\u00fcrt\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"3038_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/1352458514564488","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Stuve O et al (2015) The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review. Mult Scler 21:332\u2013341. https:\/\/doi.org\/10.1177\/1352458514564488","journal-title":"Mult Scler"},{"key":"3038_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1054\/jocn.2000.0693","volume":"7","author":"RD Henderson","year":"2000","unstructured":"Henderson RD, Bain CJ, Pender MP (2000) The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J Clin Neurosci 7:434\u2013437. https:\/\/doi.org\/10.1054\/jocn.2000.0693","journal-title":"J Clin Neurosci"},{"key":"3038_CR3","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/brain\/123.6.1102","volume":"123","author":"SA Broadley","year":"2000","unstructured":"Broadley SA, Deans J, Sawcer SJ et al (2000) Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123:1102\u20131111. https:\/\/doi.org\/10.1093\/brain\/123.6.1102","journal-title":"Brain"},{"key":"3038_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1034\/j.1600-0404.2000.101001036.x","volume":"101","author":"O Heinzlef","year":"2000","unstructured":"Heinzlef O, Alamowitch S, Sazdovitch V et al (2000) Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurol Scand 101:36\u201340. https:\/\/doi.org\/10.1034\/j.1600-0404.2000.101001036.x","journal-title":"Acta Neurol Scand"},{"key":"3038_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1177\/1352458512438240","volume":"18","author":"H Roshanisefat","year":"2012","unstructured":"Roshanisefat H, Bahmanyar S, Hillert J et al (2012) Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler 18:1430\u20131436. https:\/\/doi.org\/10.1177\/1352458512438240","journal-title":"Mult Scler"},{"key":"3038_CR6","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1007\/s00415-020-10107-y","volume":"268","author":"L Hauer","year":"2021","unstructured":"Hauer L, Perneczky J, Sellner J (2021) A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications. J Neurol 268:4066\u20134077. https:\/\/doi.org\/10.1007\/s00415-020-10107-y","journal-title":"J Neurol"},{"key":"3038_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1352458514564490","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Cohen J et al (2015) A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Mult Scler 21:282\u2013293. https:\/\/doi.org\/10.1177\/1352458514564490","journal-title":"Mult Scler"},{"key":"3038_CR8","doi-asserted-by":"publisher","first-page":"105637","DOI":"10.1016\/j.msard.2024.105637","volume":"87","author":"S Binzer","year":"2024","unstructured":"Binzer S, Hillert J, Manouchehrinia A (2024) Concomitant autoimmunity and risk of multiple sclerosis disability worsening. Mult Scler Relat Disord 87:105637. https:\/\/doi.org\/10.1016\/j.msard.2024.105637","journal-title":"Mult Scler Relat Disord"},{"key":"3038_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ene.70019","volume":"32","author":"V Nociti","year":"2025","unstructured":"Nociti V, Romozzi M, Prosperini L et al (2025) Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study. Eur J Neurol 32:1\u20138. https:\/\/doi.org\/10.1111\/ene.70019","journal-title":"Eur J Neurol"},{"key":"3038_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1352458514539782","volume":"21","author":"E Shugaiv","year":"2015","unstructured":"Shugaiv E, T\u00fcz\u00fcn E, K\u00fcrt\u00fcnc\u00fc M et al (2015) Uveitis as a prognostic factor in multiple sclerosis. Mult Scler 21:105\u2013107. https:\/\/doi.org\/10.1177\/1352458514539782","journal-title":"Mult Scler"},{"key":"3038_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.msard.2015.02.004","volume":"4","author":"L Chouhfeh","year":"2015","unstructured":"Chouhfeh L, Kavak KS, Teter BE, Weinstock-Guttman B (2015) Disease modifying therapies use associated with comorbid autoimmune diseases in multiple sclerosis patients. Mult Scler Relat Disord 4:228\u2013233. https:\/\/doi.org\/10.1016\/j.msard.2015.02.004","journal-title":"Mult Scler Relat Disord"},{"key":"3038_CR12","doi-asserted-by":"publisher","first-page":"103312","DOI":"10.1016\/j.autrev.2023.103312","volume":"22","author":"FF Konen","year":"2023","unstructured":"Konen FF, M\u00f6hn N, Witte T et al (2023) Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders. Autoimmun Rev 22:103312. https:\/\/doi.org\/10.1016\/j.autrev.2023.103312","journal-title":"Autoimmun Rev"},{"key":"3038_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000339757","volume":"39","author":"RA Marrie","year":"2012","unstructured":"Marrie RA, Yu BN, Leung S et al (2012) The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: A validation study using administrative data. Neuroepidemiology 39:135\u2013142. https:\/\/doi.org\/10.1159\/000339757","journal-title":"Neuroepidemiology"},{"key":"3038_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40257-018-0399-9","volume":"20","author":"CY Liu","year":"2019","unstructured":"Liu CY, Tung TH, Lee CY et al (2019) Association of Multiple Sclerosis with Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies. Am J Clin Dermatol 20:201\u2013208. https:\/\/doi.org\/10.1007\/s40257-018-0399-9","journal-title":"Am J Clin Dermatol"},{"key":"3038_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.msard.2017.02.012","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie RA, Patten SB, Tremlett H et al (2017) Increased incidence and prevalence of psoriasis in multiple sclerosis. Mult Scler Relat Disord 13:81\u201386. https:\/\/doi.org\/10.1016\/j.msard.2017.02.012","journal-title":"Mult Scler Relat Disord"},{"key":"3038_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/JID.2015.350","volume":"136","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Mallbris L, Gislason GH et al (2016) Risk of multiple sclerosis in patients with psoriasis: A Danish nationwide cohort study. J Invest Dermatol 136:93\u201398. https:\/\/doi.org\/10.1038\/JID.2015.350","journal-title":"J Invest Dermatol"},{"key":"3038_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/1352458510375708","volume":"16","author":"G Deretzi","year":"2010","unstructured":"Deretzi G, Kountouras J, Koutlas E et al (2010) Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece. Mult Scler 16:1091\u20131101. https:\/\/doi.org\/10.1177\/1352458510375708","journal-title":"Mult Scler"},{"key":"3038_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jdv.14205","volume":"31","author":"N Guido","year":"2017","unstructured":"Guido N, Cices A, Ibler E et al (2017) Multiple sclerosis association with psoriasis: a large U.S. population, single centre, retrospective cross-sectional study. J Eur Acad Dermatology Venereol 31:42\u201349. https:\/\/doi.org\/10.1111\/jdv.14205","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"3038_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/ptt.s186637","volume":"9","author":"AS Silfvast-Kaiser","year":"2019","unstructured":"Silfvast-Kaiser AS, Homan KB, Mansouri B (2019) A narrative review of psoriasis and multiple sclerosis: links and risks<. Psoriasis Targets Ther Volume 9:81\u201390. https:\/\/doi.org\/10.2147\/ptt.s186637","journal-title":"Psoriasis Targets Ther Volume"},{"key":"3038_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1352458507083444","volume":"14","author":"J Le Scanff","year":"2008","unstructured":"Le Scanff J, S\u00e8ve P, Renoux C et al (2008) Uveitis associated with multiple sclerosis. Mult Scler 14:415\u2013417. https:\/\/doi.org\/10.1177\/1352458507083444","journal-title":"Mult Scler"},{"key":"3038_CR21","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.msard.2020.102209","volume":"43","author":"TR Taylor","year":"2020","unstructured":"Taylor TR, Jacobs BM, Giovannoni G et al (2020) Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study. Mult Scler Relat Disord 43:102209. https:\/\/doi.org\/10.1016\/j.msard.2020.102209","journal-title":"Mult Scler Relat Disord"},{"key":"3038_CR22","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1007\/s12035-019-1630-2","volume":"56","author":"A de-la-Torre","year":"2019","unstructured":"de-la-Torre A, Silva-Aldana CT, Mu\u00f1oz-Ortiz J et al (2019) Uveitis and Multiple Sclerosis: Potential Common Causal Mutations. Mol Neurobiol 56:8008\u20138017. https:\/\/doi.org\/10.1007\/s12035-019-1630-2","journal-title":"Mol Neurobiol"},{"key":"3038_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/acn3.51495","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang X, Wan J, Wang M et al (2022) Multiple sclerosis and inflammatory bowel disease: A systematic review and meta-analysis. Ann Clin Transl Neurol 9:132\u2013140. https:\/\/doi.org\/10.1002\/acn3.51495","journal-title":"Ann Clin Transl Neurol"},{"key":"3038_CR24","doi-asserted-by":"publisher","first-page":"e3999","DOI":"10.1097\/MD.0000000000003999","volume":"95","author":"CC Tseng","year":"2016","unstructured":"Tseng CC, Chang SJ, Tsai WC et al (2016) Increased incidence of rheumatoid arthritis in multiple sclerosis. Med (United States) 95:e3999. https:\/\/doi.org\/10.1097\/MD.0000000000003999","journal-title":"Med (United States)"},{"key":"3038_CR25","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00415-018-8811-1","volume":"265","author":"L Lorefice","year":"2018","unstructured":"Lorefice L, Fenu G, Pitzalis R et al (2018) Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case\u2013control MRI study. J Neurol 265:1096\u20131101. https:\/\/doi.org\/10.1007\/s00415-018-8811-1","journal-title":"J Neurol"},{"key":"3038_CR26","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3174\/ajnr.A4681","volume":"37","author":"R Zivadinov","year":"2016","unstructured":"Zivadinov R, Raj B, Ramanathan M et al (2016) Autoimmune comorbidities are associated with brain injury in multiple sclerosis. Am J Neuroradiol 37:1010\u20131016. https:\/\/doi.org\/10.3174\/ajnr.A4681","journal-title":"Am J Neuroradiol"},{"key":"3038_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.clineuro.2016.09.003","volume":"150","author":"MA Sahraian","year":"2016","unstructured":"Sahraian MA, Owji M, Naser Moghadasi A (2016) Concomitant multiple sclerosis and another autoimmune disease: Does the clinical course change? Clin Neurol Neurosurg 150:92\u201395. https:\/\/doi.org\/10.1016\/j.clineuro.2016.09.003","journal-title":"Clin Neurol Neurosurg"},{"key":"3038_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000442203","volume":"46","author":"P Tettey","year":"2016","unstructured":"Tettey P, Siejka D, Simpson S et al (2016) Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis. Neuroepidemiology 46:106\u2013113. https:\/\/doi.org\/10.1159\/000442203","journal-title":"Neuroepidemiology"},{"key":"3038_CR29","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/jdv.14403","volume":"31","author":"G Miron","year":"2017","unstructured":"Miron G, Gurevich M, Baum S et al (2017) Psoriasis comorbidity affects multiple sclerosis neurological progression: a retrospective case \u2013 control analysis. J Eur Acad Dermatology Venereol 31:2055\u20132061. https:\/\/doi.org\/10.1111\/jdv.14403","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"3038_CR30","doi-asserted-by":"publisher","first-page":"175628642110355","DOI":"10.1177\/17562864211035542","volume":"14","author":"T Brummer","year":"2021","unstructured":"Brummer T, Ruck T, Meuth SG et al (2021) Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders. Ther Adv Neurol Disord 14:17562864211035542. https:\/\/doi.org\/10.1177\/17562864211035542","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03038-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T13:37:52Z","timestamp":1786455472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03038-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3038"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03038-4","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Istanbul University Clinical Research Ethics Committee (2020\/1064). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"<b>Ethics approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Gemini to assist with the rephrasing of complex scientific content for enhanced clarity and readability. After using this tool\/service, the authors reviewed and edited the content as needed and took full responsibility for the content of the publication.","order":3,"name":"Ethics","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}